BridgeMD
New treatment option for Eclampsia
Official title Point-of-care Ultrasound Abnormalities in Eclampsia
ClinicalTrials.gov ID: NCT05678062
What this study is testing
- What it's testing
- Preeclampsia (PE) and eclampsia remain leading causes of maternal morbidity and mortality, in both high-, low-and-middle-income countries. Preeclampsia is a complex, multisystem disease which, in its severe form, affects the cardiovascular, renal, hepatic, neurological and haematological systems.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Diagnosis of preeclampsia following ACOG definition with new onset of tonic-clonic seizures.
You likely can't join if
- Chronic pulmonary disease
- Collagen disorders
- HIV infection if CD4 count \<200 cells/ mm3
- Chronic renal or hepatic disease
- Urinary tract infection
- Sepsis
See the full eligibility criteria
- Diagnosis of preeclampsia following ACOG definition with new onset of tonic-clonic seizures.
- Chronic pulmonary disease
- Collagen disorders
- HIV infection if CD4 count \<200 cells/ mm3
- Chronic renal or hepatic disease
- Urinary tract infection
- Sepsis
- Body mass index (BMI) \> 50 kg/m2
- History of seizure disorder
- Intracranial haemorrhage
- History of benign or malignant intracranial neoplasia
The study team makes the final eligibility decision.
Where it's taking place
- Cape Town, Western Cape, South Africa
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cape Town, Western Cape, South Africa. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.